Medications ›testosterone enanthate

testosterone enanthate

RxCUI 37859 precise ingredient

Contraindicated with · 34

Diagnoses11

Breast Neoplasms, Male Prostatic Hyperplasia Genital Neoplasms, Male Genital Diseases, Male Renal Insufficiency Heart Failure Genital Diseases, Female Hemorrhage Pregnancy Reproduction Drug Hypersensitivity

Condition families23

Prostatic Neoplasms Prostatic Diseases Breast Neoplasms Breast Diseases Urogenital Neoplasms Genital Diseases Kidney Diseases Neoplasms by Site Heart Diseases Reproductive Physiological Phenomena Urologic Diseases Neoplasms Male Urogenital Diseases Female Urogenital Diseases Skin Diseases Female Urogenital Diseases and Pregnancy Complications Skin and Connective Tissue Diseases Cardiovascular Diseases Urogenital Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Drug-Related Side Effects and Adverse Reactions Chemically-Induced Disorders

Indicated for · 10

Diagnoses2

Puberty, Delayed Hypogonadism

Condition families8

Gonadal Disorders Breast Neoplasms Breast Diseases Endocrine System Diseases Neoplasms by Site Neoplasms Skin Diseases Skin and Connective Tissue Diseases

MED-RT, published by the VA through NLM. Relationships attach at the ingredient level, not to a specific product or dose.

RADV audits Coding jobs Chart counter Hours & decimal time About Contact Help Terms Privacy

Innova Coding Suite extension — both tools in your browser: Add to Chrome · Add to Edge

InnovaRx — Innova Health Strategies. ICD-10-CM and the CMS-HCC risk adjustment models are published by CMS and NCHS and are in the public domain. Effective date 2026-10-22 travels in the URL, so this link shows anyone exactly what you see.